Persistent Opioid Use After Wisdom Tooth Extraction
Calista M Harbaugh, Romesh P Nalliah, Hsou Mei Hu, Michael J Englesbe, Jennifer F Waljee, Chad M Brummett, Calista M Harbaugh, Romesh P Nalliah, Hsou Mei Hu, Michael J Englesbe, Jennifer F Waljee, Chad M Brummett
Abstract
This pharmacoepidemiology study uses commercial claims database data to describe the rate of persistent opioid use among patients aged 13 to 30 years prescribed perioperative opioids for wisdom tooth extraction.
Conflict of interest statement
Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Waljee reported receiving research funding from the Agency for Healthcare Research and Quality (grant K08 1K08HS023313-01), the American College of Surgeons, and the American Foundation for Surgery of the Hand; and serving as an unpaid consultant for 3M Health Information Systems. Dr Brummett reported holding a patent for peripheral perineural dexmedetomidine licensed to University of Michigan; being a consultant for Recro Pharma and Heron Therapeutics; and receiving research funding from Neuros Medical. No other disclosures were reported.
Source: PubMed